PMC9676472_01
Timeline of treatment for patient #1 and #2. Keys: beva, bevacizumab; cmab, cetuximab; FU, follow-up; mCRC, metastatic colorectal cancer; NGS, next genome sequencing; OS, overall survival; pmab, panitumumab; PD, progressive disease; PR, partial response; RAR, rectal anterior resection; rego, regorafenib; RT, radiotherapy; SC, short-course; SD, stable disease.
fonc-12-1030232-g001.jpg
PMC9676472_02_fonc-12-1030232-g001.jpg
f1
However, the patient died on August 20th 2021 ( Figure 1  and  Table 1 ).
PMC9676472_02
Timeline of treatment for patient #1 and #2. Keys: beva, bevacizumab; cmab, cetuximab; FU, follow-up; mCRC, metastatic colorectal cancer; NGS, next genome sequencing; OS, overall survival; pmab, panitumumab; PD, progressive disease; PR, partial response; RAR, rectal anterior resection; rego, regorafenib; RT, radiotherapy; SC, short-course; SD, stable disease.
fonc-12-1030232-g001.jpg
PMC9676472_02_fonc-12-1030232-g001.jpg
f1
However, the patient died on August 20th 2021 ( Figure 1  and  Table 1 ).